Methods for assaying MC1R variants and mitochondrial markers in skin samples

Details for Australian Patent Application No. 2008310257 (hide)

Owner Genesis Genomics Inc.

Inventors Maki, Katrina; Maggrah, Andrea; Dakubo, Gabriel; Birch-Machin, Mark; Creed, Jennifer; Robinson, Kerry; Reguly, Brian; Harbottle, Andrew; Thayer, Robert; Parr, Ryan

Agent Freehills

Pub. Number AU-A-2008310257

PCT Pub. Number WO2009/046535

Priority PCT/ CA2007/001790 11.10.07 CA; 60/999,074 15.10.07 US

Filing date 14 October 2008

Wipo publication date 16 April 2009

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

C12N 15/16 (2006.01) Mutation or genetic engineering - Hormones

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/046535 Priority application(s): WO2009/046535

9 September 2010 Alteration of Name

  The name of the applicant has been altered to Mitomics Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310259-Treatment of lignocellutosic materials utilizing disc refining and enzymatic hydrolysis performed under vacuum

2008310248-Apparatus for purifying molecules